GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » FCF Yield %

Pharmaresearch Bio Co (XKRX:217950) FCF Yield % : 2.88 (As of May. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Pharmaresearch Bio Co's Trailing 12-Month Free Cash Flow is ₩3,313 Mil, and Market Cap is ₩115,358 Mil. Therefore, Pharmaresearch Bio Co's FCF Yield % for today is 2.88%.

The historical rank and industry rank for Pharmaresearch Bio Co's FCF Yield % or its related term are showing as below:

XKRX:217950' s FCF Yield % Range Over the Past 10 Years
Min: -8.07   Med: 2.07   Max: 4.07
Current: 2.88


During the past 6 years, the highest FCF Yield % of Pharmaresearch Bio Co was 4.07%. The lowest was -8.07%. And the median was 2.07%.

XKRX:217950's FCF Yield % is ranked better than
92.54% of 1554 companies
in the Biotechnology industry
Industry Median: -14.415 vs XKRX:217950: 2.88

Pharmaresearch Bio Co's FCF Margin % for the quarter that ended in Dec. 2023 was 16.54%.


Pharmaresearch Bio Co FCF Yield % Historical Data

The historical data trend for Pharmaresearch Bio Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co FCF Yield % Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial -5.66 1.11 2.47 2.85 4.06

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield % Get a 7-Day Free Trial -5.66 1.11 2.47 2.85 4.06

Competitive Comparison of Pharmaresearch Bio Co's FCF Yield %

For the Biotechnology subindustry, Pharmaresearch Bio Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaresearch Bio Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Pharmaresearch Bio Co's FCF Yield % falls into.



Pharmaresearch Bio Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Pharmaresearch Bio Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=3312.558 / 81643.989
=4.06%

Pharmaresearch Bio Co's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=3312.558 * 1 / 81643.989
=4.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaresearch Bio Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Pharmaresearch Bio Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaresearch Bio Co (XKRX:217950) Business Description

Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines